Disc Medicine Inc expected to post a loss of $1.11 a share - Earnings Preview

Disc Medicine

07/08/2024 16:48

* Disc Medicine Inc  IRON.OQ   IRON.O  is expected to show
no
change in quarterly revenue when it reports  results on August 9
(estimated) for the period ending January 1 0001
    * 
    * ​LSEG's mean analyst estimate for Disc Medicine Inc is for
a
loss of $1.11 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Disc
Medicine Inc
is $70.00​, above​ its last closing price of $42.11. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -1.01       -1.00      -1.09     Missed  -9.1
 Dec. 31 2024              -0.78      -0.90     Missed  -15.8
 Sep. 30 2023  -0.80       -0.80      -0.58     Beat    27.6​
 Jun. 30 2023  -0.86       -0.86      -0.74     Beat    14.2
 ​​Mar.        -0.68       -0.68      -1.20     Missed  -76.9
 31 2023                                                
 Dec. 31 2022  -0.76       -0.76      -1.22     Missed  -60.5​
 Jun. 30 2022              -2.00      -1.60     Beat    20
 This summary was machine generated August 7 at 15:48 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)